Peiying Liu resumes & CV records
Resumes
Peiying Liu
Peiying Pat Liu, 652326 Lakeview Dr, Yardley, PA 19067
Peiying Liu Phones & Addresses
2326 Lakeview Dr, Morrisville, PA 19067
Yardley, PA
Jacksonville, FL
Richland, WA
Plainsboro, NJ
Villanova, PA
Ringling, OK
Buck, PA
Mentions for Peiying Pat Liu
Publications & IP owners
Us Patents
Tgf Beta Receptor Antagonists
US Patent:
2019033, Nov 7, 2019
Filed:
Jan 3, 2018
Appl. No.:
16/475413
Inventors:
- Princeton NJ, US
Upender Velaparthi - Princeton Junction NJ, US
Chetan Padmakar Darne - Ewing NJ, US
Peiying Liu - Marlborough MA, US
Manjunatha Narayana Rao Kamble - Bangalore, IN
Balaji Seshadri - Hosur, IN
Raju Mannoori - Bangalore, IN
Hasibur Rahaman - Bangalore, IN
Jayakumar Sankara Warrier - Bangalore, IN
Upender Velaparthi - Princeton Junction NJ, US
Chetan Padmakar Darne - Ewing NJ, US
Peiying Liu - Marlborough MA, US
Manjunatha Narayana Rao Kamble - Bangalore, IN
Balaji Seshadri - Hosur, IN
Raju Mannoori - Bangalore, IN
Hasibur Rahaman - Bangalore, IN
Jayakumar Sankara Warrier - Bangalore, IN
International Classification:
C07D 471/04
C07D 401/14
C07D 487/04
C07D 401/14
C07D 487/04
Abstract:
The invention relates generally to compounds of formula (I) that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and N disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
Substituted Bicyclic Heteroaryl Compounds
US Patent:
2014023, Aug 21, 2014
Filed:
Sep 27, 2012
Appl. No.:
14/347893
Inventors:
- Princeton NJ, US
Audris Huang - New Hope PA, US
Upender Velaparthi - Cheshire CT, US
Peiying Liu - Madison CT, US
Audris Huang - New Hope PA, US
Upender Velaparthi - Cheshire CT, US
Peiying Liu - Madison CT, US
International Classification:
C07D 487/04
C07D 417/14
C07D 413/14
C07D 413/06
C07D 471/04
C07D 417/14
C07D 413/14
C07D 413/06
C07D 471/04
US Classification:
51425203, 5462721, 514338, 544333, 514256, 546144, 514307, 544319, 514269, 546122, 514300, 544282, 5142591, 544122, 546256, 514333, 5462697, 544405, 51425505, 544295, 544238, 5142338
Abstract:
Disclosed are azaindazole compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein: X is O and Y is N; or X is S and Y is CH; Z is CRor N; Q is a heteroaryl; and Ris defined herein. Also disclosed are methods of using such compounds in the treatment of at least one CYP17 associated condition, such as, for example, cancer, and pharmaceutical compositions comprising such compounds.
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.